FDA Needs New Regulatory Model In Face Of Globalization, Woodcock Says
This article was originally published in The Tan Sheet
Executive Summary
The FDA requires a new regulatory model to confront issues presented by globalization, which will include reliance on foreign regulators, according to agency Chief Medical Officer Janet Woodcock